Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

543
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
543
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

844
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
844
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

941
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
941
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

479
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
479
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>In vitro</i> dormancy models improve ability to predict treatment response in severe marmoset tuberculosis lesions.

bioRxiv : the preprint server for biology·2026
Same author

Population-level genome sequencing reveals distinct Mycobacterium tuberculosis intrahost mutational trajectories in simian immunodeficiency virus co-infected and antiretroviral treated non-human primates.

bioRxiv : the preprint server for biology·2026
Same author

The immunometabolic topography of cellular organization and bacterial control in tuberculosis granulomas.

Nature immunology·2026
Same author

Impacts of heminode disruption on auditory processing of noisy sound stimuli.

bioRxiv : the preprint server for biology·2026
Same author

A novel machine-learning based optimization: identifying new treatment regimens for tuberculosis.

Numerical algebra, control and optimization·2025
Same author

GEODE: an <i>in silico</i> tool that translates <i>in vitro</i> to <i>in vivo</i> predictions of tuberculosis antibiotic combination efficacy.

Frontiers in pharmacology·2025

Related Experiment Video

Updated: Jan 18, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K

Distinct mechanisms drive post-antibiotic Tuberculosis relapse post-cure versus post-treatment-failure.

Christian T Michael1, Maral Budak1, Philana Ling Lin2

  • 1Kirschner lab, Department of Microbiology & Immunology, University of Michigan - Michigan Medicine, Ann Arbor, MI, USA.

Biorxiv : the Preprint Server for Biology
|January 16, 2026
PubMed
Summary

Tuberculosis relapse is driven by either persistent non-replicating bacteria or a threshold of replicating bacteria. Understanding these mechanisms can personalize treatment and potentially shorten therapy duration for tuberculosis (TB).

More Related Videos

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.3K
Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis
07:32

Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis

Published on: March 28, 2025

1.1K

Related Experiment Videos

Last Updated: Jan 18, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.3K
Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis
07:32

Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis

Published on: March 28, 2025

1.1K

Area of Science:

  • Computational biology and infectious disease modeling.
  • Pharmacodynamics and treatment optimization for tuberculosis.

Background:

  • Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), infects a quarter of the global population.
  • Incomplete TB treatment leads to drug resistance and post-treatment relapse, posing a significant public health challenge.
  • Two primary mechanisms, persistence and threshold, are hypothesized to drive TB relapse, complicating treatment strategies.

Purpose of the Study:

  • To computationally model whole-host Mtb infection dynamics to examine relapse mechanisms.
  • To differentiate between persistence-driven and threshold-driven relapse based on diagnostic criteria and pre-treatment bacterial burden.
  • To assess the impact of different TB treatment regimens on false cure rates and subsequent relapse.

Main Methods:

  • Development and utilization of a computational model simulating Mtb infection dynamics within a host.
  • Simulation of various diagnostic criteria and relapse definitions, including post-treatment completion and post-cure diagnosis.
  • Analysis of how pre-treatment bacterial burden and specific diagnostic tests influence relapse prediction.

Main Results:

  • False cure rates are regimen-dependent, with older regimens like HRZE showing higher rates than newer ones (RMZE, BPaL).
  • Post-cure relapse is predominantly driven by the reactivation of non-replicating Mtb (persistence).
  • Threshold-driven relapse is more common when a 'cured' status is not a strict inclusion criterion.

Conclusions:

  • Relapse mechanisms in tuberculosis are complex and depend on diagnostic definitions and treatment regimens.
  • Personalized relapse prediction and treatment may be possible by targeting non-replicating Mtb in patients with negative diagnostic results.
  • Understanding persistence and threshold dynamics can inform strategies to shorten TB treatment durations and combat drug resistance.